Tumores Triplo Negativos: O que precisamos saber em 2020?
Confira os artigos sobre o tema da nossa Reunião de Outubro
Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with earlystage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
Pembrolizumab for Early Triple-Negative Breast Cancer
Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges
Novas perspectivas no tratamento dos Tumores Luminais.
Confira os artigos sobre o tema da nossa Reunião de Agosto
Overall survival according to type of surgery in young (40 years)
Management of breast cancer in very young women
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor–Positive Breast Cancer
Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
Standard Pathologic Features Can Be Used to Identify a Subset of Estrogen Receptor Positive, HER2 Negative Patients Likely to Benefit From Neoadjuvant Chemotherapy
How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?
Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27
Does a positive axillary lymph node needle biopsy predict the need for an axillary lymph node dissection in clinically node-negative breast cancer patients in the ACOSOG Z0011 era?
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy
Manejo das pacientes portadoras de mutações genéticas
Confira os artigos sobre o tema da nossa Reunião de Julho.
BRCA Mutations and Breast Cancer Prevention
Survival after bilateral risk‑reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers
Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer
Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
Manejo do câncer de mama em mulheres jovens
Confira os artigos sobre o tema da nossa Reunião de Maio.
Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor–Positive Breast Cancer
Overall survival according to type of surgery in young (40 years) early breast cancer patients: A systematic meta-analysis comparing breast-conserving surgery versus mastectomy
Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/ HER2-Negative Breast Cancer
Local Recurrence and Breast Oncological Surgery in Young Women With Breast Cancer
Radiation therapy for young women with early breast cancer: Current state of the art
The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Seguimento radiológico pós-tratamento cirúrgico do câncer de mama
Confira a seleção de artigos científicos sobre o tema disponíveis para download:
Primary breast cancer: ESMO Clinical PracticeGuidelines for diagnosis, treatment and follow-up
Breast Cancer Screening With Mammography PlusUltrasonography or Magnetic Resonance Imagingin Women 50 Years or Younger at Diagnosis and TreatedWith Breast Conservation Therapy
Analysis of Skin Flap Thickness and ResidualBreast Tissue After Mastectomy
Questões atuais no tratamento cirúrgico do câncer de mama
Confira a seleção de artigos científicos sobre o tema disponíveis para download:
Extreme Oncoplasty: Expanding Indications for Breast Conservation
Comparison of breast-conserving surgery with mastectomy in locally advanced breast cancer after good response to neoadjuvant chemotherapy
The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) trial
Aplicações baseadas em evidências do uso do PET/CT em câncer de mama
Confira seleção de artigos científicos sobre o tema e disponíveis para download:
PET/CT for Patients With Breast
Cancer: Where Is the Clinical Impact?
Performance of FDG PET/CT in the Clinical Management of Breast Cancer
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival AmongWomen With Invasive Breast Cancer and Sentinel Node Metastasis
Indicações atuais de Esvaziamento Axilar
Confira seleção de artigos científicos sobre o tema e disponíveis para download:
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases
The Extent of Extracapsular Extension May Influence the Need for Axillary Lymph Node Dissection in Patients with T1-T2 Breast Cancer
Association of breast cancer with papillary lesions identified atpercutaneous image-guided breast biopsy
Is Low-Volume Disease in the Sentinel Node After NeoadjuvantChemotherapy an Indication for Axillary Dissection?
Atualização em tumores triplos negativos
Confira seleção de artigos científicos sobre o tema e disponíveis para download:
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
PALOMA 3 - Marcadores de resposta
Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
Refinement of Triple-Negative Breast Cancer
TNBC x tipo de cirurgia - Abdulkarim
Insights into Molecular Classifi cations of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
Refinement of Triple-Negative Breast CancerMolecular Subtypes: Implications forNeoadjuvant Chemotherapy Selection
Síndromes genéticas no câncer de mama: como identificar e conduzir
Confira seleção de artigos científicos sobre o tema e disponíveis para download:
Check 2_ATM Challenges
Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
A Study of Over 35,000 Women With Breast Cancer Tested With a 25-Gene Panel of Hereditary Cancer Genes
Hereditary_Genetic_Testing_Patients_With_Without_Breast_Cancer
A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer
Underdiagnosis of Hereditary Breast Cancer: AreGenetic Testing Guidelines a Tool or an Obstacle?
Consensus Guideline on Genetic Testing for Hereditary Breast Cancer